Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elżbieta Wójcik
Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy
OnCOReview
Oncology
Related publications
Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
PLoS ONE
Multidisciplinary
Safety and Efficacy of Pegylated Liposomal Doxorubicin in HIV-associated Kaposi’s Sarcoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin
Clinical Medicine Reviews in Women's Health
Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Non‑pegylated Liposomal Doxorubicin for Patients With Recurrent Ovarian Cancer: A Multicentric Phase II Trial
Oncology Letters
Cancer Research
Oncology
A Systematic Review and Economic Evaluation of Pegylated Liposomal Doxorubicin Hydrochloride for Ovarian Cancer
Health Technology Assessment
Medicine
Health Policy
Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)
Scientific Reports
Multidisciplinary
A Retrospective Analysis of Pegylated Liposomal Doxorubicin in Ovarian Cancer: Do We Still Need It?
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Pegylated Liposomal Doxorubicin in the Treatment of Primary Cutaneous T-Cell Lymphomas
Haematologica
Hematology